3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Neoplasm Metastasis
4
Colorectal Neoplasms
2
Pancreatic Neoplasms
1
Neoplasms
1
HER2-Positive Primary Breast Cancer
1
Gastrointestinal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Diseases
1
Adenocarcinoma
1
Interventions
pembrolizumab
3
tisotumab vedotin
2
Cisplatin
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
sacituzumab govitecan
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Vinorelbine
1
Trastuzumab
1
Topotecan
1
Sunitinib
1
Specimen Handling
1
Saline Solution
1
Pemetrexed
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Uterine Cervical Neoplasms
×
trastuzumab deruxtecan
×
Clear all
No trials found.